IRTC IPOs 7.29M* shares @$17.00—closes +53% on first day: http://finance.yahoo.com/news/irhythm-technologies-announces-pricing-initial-040100817.html iRhythm is a commercial-stage digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. …The company’s platform, the Zio Service, has been provided to over 500,000 patients, accumulating more than 125 million hours of curated heartbeat data… The IPO price and the offering size were increased due to high demand. *Assuming exercise of underwriter's option.